clinical trials for tirzepatide SURMOUNT-3 study design This is a phase 3, multicenter, randomized, Tirzepatide for Weight Loss |

8 Data from a phase 2 trial of 338 adults with obesity without diabetes suggests substantial weight loss benefit with retatrutide, with 26% of participants having a body weight reduction of 30% with the highest dose of retatrutide (12 mg SC once weekly)

However, we believe that the optimal frequency should be determined by our healthcare professionals based on your individual assessment

Allulose is a rare sugar that provides the sweetness of sugar without impacting blood glucose or insulin

The organization represents professionals who lead the business offices of roughly 15,000 medical practices

Unlike protein which remains relatively fixed regardless of activity, carbohydrate intake should vary based on training demands

Clinical Evidence on Semaglutide and Liver Enzymes Several clinical trials have investigated the effects of semaglutide on liver enzymes